Search Results

You are looking at 251 - 260 of 1,592 items for :

  • "characteristics" x
  • Refine by Access: All x
Clear All
Full access

Trends in the Incidence and Outcomes of Hospitalized Cancer Patients With Clostridium difficile Infection: A Nationwide Analysis

Arjun Gupta, Raseen Tariq, Ryan D. Frank, Gary W. Jean, Muhammad S. Beg, Darrell S. Pardi, David H. Johnson, and Sahil Khanna

accessible online at http://www.cdc.gov/nchs/nhds.htm . All diagnoses are based on ICD-9-CM codes. Data Collection Data collected and analyzed included age, sex, race, admission type (urgent/emergent vs elective), hospital characteristics, LOS

Full access

Comparison of Treatment Strategies for Patients With Clinical Stage T1–3/N2 Lung Cancer

Ya-Fu Cheng, Wei-Heng Hung, Heng-Chung Chen, Ching-Yuan Cheng, Ching-Hsiung Lin, Sheng-Hao Lin, and Bing-Yen Wang

excluded if they received no therapy or if their database records were missing values for therapy or type of surgery. Baseline patient demographics (age and sex), tumor characteristics (histologic grade, cell type, T stage), and treatment details (surgery

Full access

Relationship Between Perceptions of Treatment Goals and Psychological Distress in Patients With Advanced Cancer

Areej El-Jawahri, Deborah Forst, Alyssa Fenech, Keri O. Brenner, Amanda L. Jankowski, Lauren Waldman, Isabella Sereno, Ryan Nipp, Joseph A. Greer, Lara Traeger, Vicki Jackson, and Jennifer Temel

, relationship status, or time since diagnosis of incurable cancer and patient-reported QoL or mood. Table 1. Participant Characteristics Patients’ Perceptions of Both Their Treatment Goal and Their Oncologist’s Goal Figure 1 depicts patients’ perceptions of

Full access

Impact of Provider Imaging Practices on Survival Outcomes in Advanced Ovarian Cancer

Angela K. Green, Deborah Korenstein, Carol Aghajanian, Brooke Barrow, Michael Curry, and Roisin E. O’Cearbhaill

patients who underwent SCS by imaging practices. Characteristics between patients treated by high- versus low-frequency imaging providers were compared using chi-square tests for discrete variables and t tests for continuous variables. Because CA-125

Full access

Intravenous Patient-Controlled Analgesia Versus Oral Opioid to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase II Trial

Rongbo Lin, Jinfeng Zhu, Yushuang Luo, Xia Lv, Mingqian Lu, Haihui Chen, Huichao Zou, Zhichun Zhang, Shaowei Lin, Milu Wu, Xiaofeng Li, Min Zhou, Shen Zhao, Liyu Su, Jiang Liu, and Cheng Huang

or avNRS among the 3 arms ( Table 1 ). Other baseline characteristics were well balanced between the 3 groups, with comparable ESAS symptom severity ( supplemental eTable 2 and Table 1 ). Figure 1. Study profile. (A1) Bolus-only arm, (A2

Full access

Neuroendocrine Tumors

Matthew H. Kulke, Al B. Benson III, Emily Bergsland, Jordan D. Berlin, Lawrence S. Blaszkowsky, Michael A. Choti, Orlo H. Clark, Gerard M. Doherty, James Eason, Lyska Emerson, Paul F. Engstrom, Whitney S. Goldner, Martin J. Heslin, Fouad Kandeel, Pamela L. Kunz, Boris W. Kuvshinoff II, Jeffrey F. Moley, Venu G. Pillarisetty, Leonard Saltz, David E. Schteingart, Manisha H. Shah, Stephen Shibata, Jonathan R. Strosberg, Jean-Nicolas Vauthey, Rebekah White, James C. Yao, Deborah A. Freedman-Cass, and Mary A. Dwyer

< 5% of patients) are not specifically discussed in these guidelines. Histologic Classification and Staging of Neuroendocrine Tumors Neuroendocrine tumors are generally subclassified by site of origin and histologic characteristics. Pancreatic

Full access

Impact of Facility Surgical Volume on Survival in Patients With Cancer

Kelsey C. Stoltzfus, Biyi Shen, Leila Tchelebi, Daniel M. Trifiletti, Niraj J. Gusani, Vonn Walter, Ming Wang, and Nicholas G. Zaorsky

insurance (51.6%), and had stage 0–III disease (64.8%). Patients traveled an average of 30.9 miles to get to their treatment facility. These results are summarized in Table 1 . Table 1. Patient Characteristics Surgical facility volume

Full access

Comparison of Cancer Burden and Nonprofit Organization Funding Reveals Disparities in Funding Across Cancer Types

Suneel D. Kamath, Sheetal M. Kircher, and Al B. Benson III

amount of annual revenue supporting each cancer type. Table 1. Characteristics of Nonprofit Organizations Among cancer type–specific NPOs, the cancers with the largest number of organizations were breast cancer (13; 22%), pediatric cancers (13; 22

Full access

Nonoperative Treatment of Large (5–7 cm), Node-Negative Non–Small Cell Lung Cancer Commonly Deviates From NCCN Guidelines

Craig S. Schneider, Robert A. Oster, Aparna Hegde, Michael C. Dobelbower, John M. Stahl, and Adam J. Kole

chemotherapy. Most patients received CFRT (64.3%), whereas SBRT (21.8%) and HFRT (13.9%) were less common. The most commonly used RT fractionation regimen for each category can be found in supplemental eTable 1 . Table 1. Patient Characteristics

Full access

New Therapies for Ovarian Cancer

Deborah K. Armstrong

patients receive chemotherapy with paclitaxel and carboplatin. In early-stage nonserous epithelial ovarian cancer, 3 cycles have been shown to be as effective as 6 Figure 1. Characteristics of ovarian cancer subtypes. Abbreviation: MP